Global Cystoscope Market review

Cystoscope Comprehensive Study by Type (Rigid Cystoscope, Flexible Cystoscope), Application (Urology, Gynaecology), End User (Hospitals & Clinics, Ambulatory Surgical Centers) Players and Region - Global Market Outlook to 2028

Cystoscope Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Cystoscope
The global cystoscope market is expected to witness significant growth during the forecast period owing to the rising prevalence of bladder cancer and other urological disorders and increasing prevalence of urinary retention and incontinence. Cystoscopy is a procedure which allows to doctor to examine the lining of patients bladder and the tube which carries urine out of the body (urethra). Furthermore, a hollow tube i.e. cystoscope fortified with a lens is inserted into the urethra and slowly advanced into the bladder.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The global cystoscope market is fragmented, with large and medium size players accounting for the majority of market profits. Many players are arranging various strategies, entering into merger and acquisition and introducing more effective cystoscope. Analyst at AMA Research estimates that United States and German Players will contribute the maximum growth to Global Cystoscope market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Stryker Corporation (United States), PENTAX Medical (United States), Olympus Corporation (Japan), Richard Wolf GmbH (Germany), Karl Storz (Germany), NeoScope Inc. (United States), Coloplast Group (Denmark), Maxer Medizintechnik GmbH (Germany), Advanced Endoscopy Devices, Inc. (United States) and Laborie (Canada) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Hoya Corporation (Japan) and Henke-Sass Wolf (Germany).

Segmentation Overview
AMA Research has segmented the market of Global Cystoscope market by Type (Rigid Cystoscope and Flexible Cystoscope), Application (Urology and Gynaecology) and Region. On the basis of Type, Rigid Cystoscope are dominating the market in the year 2022 where as Flexible Cystoscope stood as second largest market share.

On the basis of application, Urology segment is dominating the market in the year 2022 where as Gynaecology segment stood as second largest market .

On the basis of geography, the market of Cystoscope has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Hospitals & Clinics will boost the Cystoscope market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Developments in Cystoscope Technology

Market Growth Drivers:
Rising Prevalence of Bladder Cancer and Other Urological Disorders and Increasing Prevalence of Urinary Retention and Incontinence

Challenges:
High Risk of Infections Post Cystoscopy Procedure

Restraints:
High-Cost Associated With Cystoscopy

Opportunities:
Advancements in Disposable Cystoscopes

Market Leaders and their expansionary development strategies

On August 22, 2023, Karl Storz SE & Co. KG introduced its new rigid cystoscope, the C-SYS2™. The C-SYS2™ is equipped with a number of advanced features, including a high-resolution camera, LED lighting, and integrated software for image capture and analysis. The product is expected to be particularly beneficial for urologists performing minimally invasive procedures.
FDA's Center for Devices and Radiological Health (CDRH) is responsible for regulating firms who manufacture, repackage, relabel, and/or import medical devices sold in the United States. In addition, CDRH regulates radiation-emitting electronic products (medical and non-medical) such as lasers, x-ray systems, ultrasound equipment, microwave ovens and color televisions.

Key Target Audience
Cystoscope Treatment Provider, Medical Equipment Providers, Healthcare Industry, Governmental Bodies, Hospitals and Research Firms

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Rigid Cystoscope
  • Flexible Cystoscope
By Application
  • Urology
  • Gynaecology
By End User
  • Hospitals & Clinics
  • Ambulatory Surgical Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Bladder Cancer and Other Urological Disorders
      • 3.2.2. Increasing Prevalence of Urinary Retention and Incontinence
    • 3.3. Market Challenges
      • 3.3.1. High Risk of Infections Post Cystoscopy Procedure
    • 3.4. Market Trends
      • 3.4.1. Developments in Cystoscope Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cystoscope, by Type, Application, End User and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Cystoscope (Value)
      • 5.2.1. Global Cystoscope by: Type (Value)
        • 5.2.1.1. Rigid Cystoscope
        • 5.2.1.2. Flexible Cystoscope
      • 5.2.2. Global Cystoscope by: Application (Value)
        • 5.2.2.1. Urology
        • 5.2.2.2. Gynaecology
      • 5.2.3. Global Cystoscope by: End User (Value)
        • 5.2.3.1. Hospitals & Clinics
        • 5.2.3.2. Ambulatory Surgical Centers
      • 5.2.4. Global Cystoscope Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Cystoscope (Price)
      • 5.3.1. Global Cystoscope by: Type (Price)
  • 6. Cystoscope: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Stryker Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. PENTAX Medical (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Olympus Corporation (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Richard Wolf GmbH (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Karl Storz (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. NeoScope Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Coloplast Group (Denmark)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Maxer Medizintechnik GmbH (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Advanced Endoscopy Devices, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Laborie (Canada)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Cystoscope Sale, by Type, Application, End User and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Cystoscope (Value)
      • 7.2.1. Global Cystoscope by: Type (Value)
        • 7.2.1.1. Rigid Cystoscope
        • 7.2.1.2. Flexible Cystoscope
      • 7.2.2. Global Cystoscope by: Application (Value)
        • 7.2.2.1. Urology
        • 7.2.2.2. Gynaecology
      • 7.2.3. Global Cystoscope by: End User (Value)
        • 7.2.3.1. Hospitals & Clinics
        • 7.2.3.2. Ambulatory Surgical Centers
      • 7.2.4. Global Cystoscope Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Cystoscope (Price)
      • 7.3.1. Global Cystoscope by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cystoscope: by Type(USD Million)
  • Table 2. Cystoscope Rigid Cystoscope , by Region USD Million (2017-2022)
  • Table 3. Cystoscope Flexible Cystoscope , by Region USD Million (2017-2022)
  • Table 4. Cystoscope: by Application(USD Million)
  • Table 5. Cystoscope Urology , by Region USD Million (2017-2022)
  • Table 6. Cystoscope Gynaecology , by Region USD Million (2017-2022)
  • Table 7. Cystoscope: by End User(USD Million)
  • Table 8. Cystoscope Hospitals & Clinics , by Region USD Million (2017-2022)
  • Table 9. Cystoscope Ambulatory Surgical Centers , by Region USD Million (2017-2022)
  • Table 10. South America Cystoscope, by Country USD Million (2017-2022)
  • Table 11. South America Cystoscope, by Type USD Million (2017-2022)
  • Table 12. South America Cystoscope, by Application USD Million (2017-2022)
  • Table 13. South America Cystoscope, by End User USD Million (2017-2022)
  • Table 14. Brazil Cystoscope, by Type USD Million (2017-2022)
  • Table 15. Brazil Cystoscope, by Application USD Million (2017-2022)
  • Table 16. Brazil Cystoscope, by End User USD Million (2017-2022)
  • Table 17. Argentina Cystoscope, by Type USD Million (2017-2022)
  • Table 18. Argentina Cystoscope, by Application USD Million (2017-2022)
  • Table 19. Argentina Cystoscope, by End User USD Million (2017-2022)
  • Table 20. Rest of South America Cystoscope, by Type USD Million (2017-2022)
  • Table 21. Rest of South America Cystoscope, by Application USD Million (2017-2022)
  • Table 22. Rest of South America Cystoscope, by End User USD Million (2017-2022)
  • Table 23. Asia Pacific Cystoscope, by Country USD Million (2017-2022)
  • Table 24. Asia Pacific Cystoscope, by Type USD Million (2017-2022)
  • Table 25. Asia Pacific Cystoscope, by Application USD Million (2017-2022)
  • Table 26. Asia Pacific Cystoscope, by End User USD Million (2017-2022)
  • Table 27. China Cystoscope, by Type USD Million (2017-2022)
  • Table 28. China Cystoscope, by Application USD Million (2017-2022)
  • Table 29. China Cystoscope, by End User USD Million (2017-2022)
  • Table 30. Japan Cystoscope, by Type USD Million (2017-2022)
  • Table 31. Japan Cystoscope, by Application USD Million (2017-2022)
  • Table 32. Japan Cystoscope, by End User USD Million (2017-2022)
  • Table 33. India Cystoscope, by Type USD Million (2017-2022)
  • Table 34. India Cystoscope, by Application USD Million (2017-2022)
  • Table 35. India Cystoscope, by End User USD Million (2017-2022)
  • Table 36. South Korea Cystoscope, by Type USD Million (2017-2022)
  • Table 37. South Korea Cystoscope, by Application USD Million (2017-2022)
  • Table 38. South Korea Cystoscope, by End User USD Million (2017-2022)
  • Table 39. Taiwan Cystoscope, by Type USD Million (2017-2022)
  • Table 40. Taiwan Cystoscope, by Application USD Million (2017-2022)
  • Table 41. Taiwan Cystoscope, by End User USD Million (2017-2022)
  • Table 42. Australia Cystoscope, by Type USD Million (2017-2022)
  • Table 43. Australia Cystoscope, by Application USD Million (2017-2022)
  • Table 44. Australia Cystoscope, by End User USD Million (2017-2022)
  • Table 45. Rest of Asia-Pacific Cystoscope, by Type USD Million (2017-2022)
  • Table 46. Rest of Asia-Pacific Cystoscope, by Application USD Million (2017-2022)
  • Table 47. Rest of Asia-Pacific Cystoscope, by End User USD Million (2017-2022)
  • Table 48. Europe Cystoscope, by Country USD Million (2017-2022)
  • Table 49. Europe Cystoscope, by Type USD Million (2017-2022)
  • Table 50. Europe Cystoscope, by Application USD Million (2017-2022)
  • Table 51. Europe Cystoscope, by End User USD Million (2017-2022)
  • Table 52. Germany Cystoscope, by Type USD Million (2017-2022)
  • Table 53. Germany Cystoscope, by Application USD Million (2017-2022)
  • Table 54. Germany Cystoscope, by End User USD Million (2017-2022)
  • Table 55. France Cystoscope, by Type USD Million (2017-2022)
  • Table 56. France Cystoscope, by Application USD Million (2017-2022)
  • Table 57. France Cystoscope, by End User USD Million (2017-2022)
  • Table 58. Italy Cystoscope, by Type USD Million (2017-2022)
  • Table 59. Italy Cystoscope, by Application USD Million (2017-2022)
  • Table 60. Italy Cystoscope, by End User USD Million (2017-2022)
  • Table 61. United Kingdom Cystoscope, by Type USD Million (2017-2022)
  • Table 62. United Kingdom Cystoscope, by Application USD Million (2017-2022)
  • Table 63. United Kingdom Cystoscope, by End User USD Million (2017-2022)
  • Table 64. Netherlands Cystoscope, by Type USD Million (2017-2022)
  • Table 65. Netherlands Cystoscope, by Application USD Million (2017-2022)
  • Table 66. Netherlands Cystoscope, by End User USD Million (2017-2022)
  • Table 67. Rest of Europe Cystoscope, by Type USD Million (2017-2022)
  • Table 68. Rest of Europe Cystoscope, by Application USD Million (2017-2022)
  • Table 69. Rest of Europe Cystoscope, by End User USD Million (2017-2022)
  • Table 70. MEA Cystoscope, by Country USD Million (2017-2022)
  • Table 71. MEA Cystoscope, by Type USD Million (2017-2022)
  • Table 72. MEA Cystoscope, by Application USD Million (2017-2022)
  • Table 73. MEA Cystoscope, by End User USD Million (2017-2022)
  • Table 74. Middle East Cystoscope, by Type USD Million (2017-2022)
  • Table 75. Middle East Cystoscope, by Application USD Million (2017-2022)
  • Table 76. Middle East Cystoscope, by End User USD Million (2017-2022)
  • Table 77. Africa Cystoscope, by Type USD Million (2017-2022)
  • Table 78. Africa Cystoscope, by Application USD Million (2017-2022)
  • Table 79. Africa Cystoscope, by End User USD Million (2017-2022)
  • Table 80. North America Cystoscope, by Country USD Million (2017-2022)
  • Table 81. North America Cystoscope, by Type USD Million (2017-2022)
  • Table 82. North America Cystoscope, by Application USD Million (2017-2022)
  • Table 83. North America Cystoscope, by End User USD Million (2017-2022)
  • Table 84. United States Cystoscope, by Type USD Million (2017-2022)
  • Table 85. United States Cystoscope, by Application USD Million (2017-2022)
  • Table 86. United States Cystoscope, by End User USD Million (2017-2022)
  • Table 87. Canada Cystoscope, by Type USD Million (2017-2022)
  • Table 88. Canada Cystoscope, by Application USD Million (2017-2022)
  • Table 89. Canada Cystoscope, by End User USD Million (2017-2022)
  • Table 90. Mexico Cystoscope, by Type USD Million (2017-2022)
  • Table 91. Mexico Cystoscope, by Application USD Million (2017-2022)
  • Table 92. Mexico Cystoscope, by End User USD Million (2017-2022)
  • Table 93. Cystoscope: by Type(USD/Units)
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Cystoscope: by Type(USD Million)
  • Table 105. Cystoscope Rigid Cystoscope , by Region USD Million (2023-2028)
  • Table 106. Cystoscope Flexible Cystoscope , by Region USD Million (2023-2028)
  • Table 107. Cystoscope: by Application(USD Million)
  • Table 108. Cystoscope Urology , by Region USD Million (2023-2028)
  • Table 109. Cystoscope Gynaecology , by Region USD Million (2023-2028)
  • Table 110. Cystoscope: by End User(USD Million)
  • Table 111. Cystoscope Hospitals & Clinics , by Region USD Million (2023-2028)
  • Table 112. Cystoscope Ambulatory Surgical Centers , by Region USD Million (2023-2028)
  • Table 113. South America Cystoscope, by Country USD Million (2023-2028)
  • Table 114. South America Cystoscope, by Type USD Million (2023-2028)
  • Table 115. South America Cystoscope, by Application USD Million (2023-2028)
  • Table 116. South America Cystoscope, by End User USD Million (2023-2028)
  • Table 117. Brazil Cystoscope, by Type USD Million (2023-2028)
  • Table 118. Brazil Cystoscope, by Application USD Million (2023-2028)
  • Table 119. Brazil Cystoscope, by End User USD Million (2023-2028)
  • Table 120. Argentina Cystoscope, by Type USD Million (2023-2028)
  • Table 121. Argentina Cystoscope, by Application USD Million (2023-2028)
  • Table 122. Argentina Cystoscope, by End User USD Million (2023-2028)
  • Table 123. Rest of South America Cystoscope, by Type USD Million (2023-2028)
  • Table 124. Rest of South America Cystoscope, by Application USD Million (2023-2028)
  • Table 125. Rest of South America Cystoscope, by End User USD Million (2023-2028)
  • Table 126. Asia Pacific Cystoscope, by Country USD Million (2023-2028)
  • Table 127. Asia Pacific Cystoscope, by Type USD Million (2023-2028)
  • Table 128. Asia Pacific Cystoscope, by Application USD Million (2023-2028)
  • Table 129. Asia Pacific Cystoscope, by End User USD Million (2023-2028)
  • Table 130. China Cystoscope, by Type USD Million (2023-2028)
  • Table 131. China Cystoscope, by Application USD Million (2023-2028)
  • Table 132. China Cystoscope, by End User USD Million (2023-2028)
  • Table 133. Japan Cystoscope, by Type USD Million (2023-2028)
  • Table 134. Japan Cystoscope, by Application USD Million (2023-2028)
  • Table 135. Japan Cystoscope, by End User USD Million (2023-2028)
  • Table 136. India Cystoscope, by Type USD Million (2023-2028)
  • Table 137. India Cystoscope, by Application USD Million (2023-2028)
  • Table 138. India Cystoscope, by End User USD Million (2023-2028)
  • Table 139. South Korea Cystoscope, by Type USD Million (2023-2028)
  • Table 140. South Korea Cystoscope, by Application USD Million (2023-2028)
  • Table 141. South Korea Cystoscope, by End User USD Million (2023-2028)
  • Table 142. Taiwan Cystoscope, by Type USD Million (2023-2028)
  • Table 143. Taiwan Cystoscope, by Application USD Million (2023-2028)
  • Table 144. Taiwan Cystoscope, by End User USD Million (2023-2028)
  • Table 145. Australia Cystoscope, by Type USD Million (2023-2028)
  • Table 146. Australia Cystoscope, by Application USD Million (2023-2028)
  • Table 147. Australia Cystoscope, by End User USD Million (2023-2028)
  • Table 148. Rest of Asia-Pacific Cystoscope, by Type USD Million (2023-2028)
  • Table 149. Rest of Asia-Pacific Cystoscope, by Application USD Million (2023-2028)
  • Table 150. Rest of Asia-Pacific Cystoscope, by End User USD Million (2023-2028)
  • Table 151. Europe Cystoscope, by Country USD Million (2023-2028)
  • Table 152. Europe Cystoscope, by Type USD Million (2023-2028)
  • Table 153. Europe Cystoscope, by Application USD Million (2023-2028)
  • Table 154. Europe Cystoscope, by End User USD Million (2023-2028)
  • Table 155. Germany Cystoscope, by Type USD Million (2023-2028)
  • Table 156. Germany Cystoscope, by Application USD Million (2023-2028)
  • Table 157. Germany Cystoscope, by End User USD Million (2023-2028)
  • Table 158. France Cystoscope, by Type USD Million (2023-2028)
  • Table 159. France Cystoscope, by Application USD Million (2023-2028)
  • Table 160. France Cystoscope, by End User USD Million (2023-2028)
  • Table 161. Italy Cystoscope, by Type USD Million (2023-2028)
  • Table 162. Italy Cystoscope, by Application USD Million (2023-2028)
  • Table 163. Italy Cystoscope, by End User USD Million (2023-2028)
  • Table 164. United Kingdom Cystoscope, by Type USD Million (2023-2028)
  • Table 165. United Kingdom Cystoscope, by Application USD Million (2023-2028)
  • Table 166. United Kingdom Cystoscope, by End User USD Million (2023-2028)
  • Table 167. Netherlands Cystoscope, by Type USD Million (2023-2028)
  • Table 168. Netherlands Cystoscope, by Application USD Million (2023-2028)
  • Table 169. Netherlands Cystoscope, by End User USD Million (2023-2028)
  • Table 170. Rest of Europe Cystoscope, by Type USD Million (2023-2028)
  • Table 171. Rest of Europe Cystoscope, by Application USD Million (2023-2028)
  • Table 172. Rest of Europe Cystoscope, by End User USD Million (2023-2028)
  • Table 173. MEA Cystoscope, by Country USD Million (2023-2028)
  • Table 174. MEA Cystoscope, by Type USD Million (2023-2028)
  • Table 175. MEA Cystoscope, by Application USD Million (2023-2028)
  • Table 176. MEA Cystoscope, by End User USD Million (2023-2028)
  • Table 177. Middle East Cystoscope, by Type USD Million (2023-2028)
  • Table 178. Middle East Cystoscope, by Application USD Million (2023-2028)
  • Table 179. Middle East Cystoscope, by End User USD Million (2023-2028)
  • Table 180. Africa Cystoscope, by Type USD Million (2023-2028)
  • Table 181. Africa Cystoscope, by Application USD Million (2023-2028)
  • Table 182. Africa Cystoscope, by End User USD Million (2023-2028)
  • Table 183. North America Cystoscope, by Country USD Million (2023-2028)
  • Table 184. North America Cystoscope, by Type USD Million (2023-2028)
  • Table 185. North America Cystoscope, by Application USD Million (2023-2028)
  • Table 186. North America Cystoscope, by End User USD Million (2023-2028)
  • Table 187. United States Cystoscope, by Type USD Million (2023-2028)
  • Table 188. United States Cystoscope, by Application USD Million (2023-2028)
  • Table 189. United States Cystoscope, by End User USD Million (2023-2028)
  • Table 190. Canada Cystoscope, by Type USD Million (2023-2028)
  • Table 191. Canada Cystoscope, by Application USD Million (2023-2028)
  • Table 192. Canada Cystoscope, by End User USD Million (2023-2028)
  • Table 193. Mexico Cystoscope, by Type USD Million (2023-2028)
  • Table 194. Mexico Cystoscope, by Application USD Million (2023-2028)
  • Table 195. Mexico Cystoscope, by End User USD Million (2023-2028)
  • Table 196. Cystoscope: by Type(USD/Units)
  • Table 197. Research Programs/Design for This Report
  • Table 198. Key Data Information from Secondary Sources
  • Table 199. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cystoscope: by Type USD Million (2017-2022)
  • Figure 5. Global Cystoscope: by Application USD Million (2017-2022)
  • Figure 6. Global Cystoscope: by End User USD Million (2017-2022)
  • Figure 7. South America Cystoscope Share (%), by Country
  • Figure 8. Asia Pacific Cystoscope Share (%), by Country
  • Figure 9. Europe Cystoscope Share (%), by Country
  • Figure 10. MEA Cystoscope Share (%), by Country
  • Figure 11. North America Cystoscope Share (%), by Country
  • Figure 12. Global Cystoscope: by Type USD/Units (2017-2022)
  • Figure 13. Global Cystoscope share by Players 2022 (%)
  • Figure 14. Global Cystoscope share by Players (Top 3) 2022(%)
  • Figure 15. Global Cystoscope share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Stryker Corporation (United States) Revenue: by Geography 2022
  • Figure 19. PENTAX Medical (United States) Revenue, Net Income and Gross profit
  • Figure 20. PENTAX Medical (United States) Revenue: by Geography 2022
  • Figure 21. Olympus Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 22. Olympus Corporation (Japan) Revenue: by Geography 2022
  • Figure 23. Richard Wolf GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Richard Wolf GmbH (Germany) Revenue: by Geography 2022
  • Figure 25. Karl Storz (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Karl Storz (Germany) Revenue: by Geography 2022
  • Figure 27. NeoScope Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. NeoScope Inc. (United States) Revenue: by Geography 2022
  • Figure 29. Coloplast Group (Denmark) Revenue, Net Income and Gross profit
  • Figure 30. Coloplast Group (Denmark) Revenue: by Geography 2022
  • Figure 31. Maxer Medizintechnik GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Maxer Medizintechnik GmbH (Germany) Revenue: by Geography 2022
  • Figure 33. Advanced Endoscopy Devices, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Advanced Endoscopy Devices, Inc. (United States) Revenue: by Geography 2022
  • Figure 35. Laborie (Canada) Revenue, Net Income and Gross profit
  • Figure 36. Laborie (Canada) Revenue: by Geography 2022
  • Figure 37. Global Cystoscope: by Type USD Million (2023-2028)
  • Figure 38. Global Cystoscope: by Application USD Million (2023-2028)
  • Figure 39. Global Cystoscope: by End User USD Million (2023-2028)
  • Figure 40. South America Cystoscope Share (%), by Country
  • Figure 41. Asia Pacific Cystoscope Share (%), by Country
  • Figure 42. Europe Cystoscope Share (%), by Country
  • Figure 43. MEA Cystoscope Share (%), by Country
  • Figure 44. North America Cystoscope Share (%), by Country
  • Figure 45. Global Cystoscope: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Stryker Corporation (United States)
  • PENTAX Medical (United States)
  • Olympus Corporation (Japan)
  • Richard Wolf GmbH (Germany)
  • Karl Storz (Germany)
  • NeoScope Inc. (United States)
  • Coloplast Group (Denmark)
  • Maxer Medizintechnik GmbH (Germany)
  • Advanced Endoscopy Devices, Inc. (United States)
  • Laborie (Canada)
Additional players considered in the study are as follows:
Hoya Corporation (Japan) , Henke-Sass Wolf (Germany)
Select User Access Type

Key Highlights of Report


Nov 2023 198 Pages 71 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Cystoscope Market review Quantitative research analysis
Global Cystoscope Market review Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Stryker Corporation (United States), PENTAX Medical (United States), Olympus Corporation (Japan), Richard Wolf GmbH (Germany), Karl Storz (Germany), NeoScope Inc. (United States), Coloplast Group (Denmark), Maxer Medizintechnik GmbH (Germany), Advanced Endoscopy Devices, Inc. (United States) and Laborie (Canada) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Developments in Cystoscope Technology" is seen as one of major influencing trends for Cystoscope Market during projected period 2022-2028.
The Cystoscope market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Cystoscope Market review Report?

Have a Query? Click Here

Other Related Reports

Diuretics Comprehensive Study by Type (Thiazide diuretics, Loop diuretics, Potassium-sparing diuretics), Application (Hypertension, Edema, Hypercalciuria, Diabetes, Insipidus, Others), Distribution C...
$ 3750
Therapeutic Vaccines Comprehensive Study by Category (Antigen Vaccines, Dendritic Cell Vaccines, DNA Vaccines, Tumor Cell Vaccines), Disease (Autoimmune Disease, Cancer, Neurological Diseases, Infect...
$ 3650
Traumatic Brain Injury Therapeutics Comprehensive Study by Type (Immediate emergency care, Medications (Diuretics, Anti-seizure drugs, Coma-inducing drugs, Anti-anxiety agents, Antidepressants, Anti-...
$ 3800
ENT Disorder Treatment Comprehensive Study by Type (Devices, Therapy, Medications (Nasal Spray, Drops, Tablets), Others), Application (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Setti...
$ 3650
Scar Treatment Comprehensive Study by Type (Surgical, Laser, Topical, Injectable, Other), Application (Hospitals, Dermatology Clinics, Other), Scar (Atrophic, Hypertrophic and Keloid, Contracture, St...
$ 3500
GERD Comprehensive Study by End Users (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), Route of Administration (Oral, Parenteral, Others), Drug Class (Antacids, Proton Pump Inhibitors, H...
$ 3800